Vitamin C down-regulates VEGF production in B16F10 murine melanoma cells via the suppression of p42/44 MAPK activation

Journal of Cellular Biochemistry

Volumn 112, Issue 3, 2011, Pages 894-901

  Kim, Ha Na ^a   Kim, Hyemin ^a   Kong, Joo Myung ^a   Bae, Seyeon ^a   Kim, Yong Sung ^a   Lee, Naeun ^a   Cho, Byung Joo ^b   Lee, Seung Koo ^a   Kim, Hang Rae ^a   Hwang, Young Il ^a   Kang, Jae Seung ^a,c   Lee, Wang Jae ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

COX 2; P42 44MAPK; VEGF; Vitamin C

Indexed keywords

ASCORBIC ACID; CYCLOOXYGENASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; PROTEIN P42; PROTEIN P44; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; MELANOMA CELL; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASCORBIC ACID; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DOWN-REGULATION; ENZYME ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITROBENZENES; PHOSPHORYLATION; SULFONAMIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 79951779841     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22997     Document Type: Article

References (47)

1. Abe T, Abe Y, Aida Y, Hara Y, Maeda K. 2001. Extracellular matrix regulates induction of alkaline phosphatase expression by ascorbic acid in human fibroblasts. J Cell Physiol 189(2):144-151. (Pubitemid 32946025)
2. Andrews NC. 2000. Iron homeostasis: Insights from genetics and animal models. Nat Rev Genet 1(3):208-217.
3. Bruick K, McKnight SL. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340. (Pubitemid 33063099)
4. Cho D, Hahm E, Kang JS, Kim YI, Yang Y, Park JH, Kim D, Kim S, Kim YS, Hur D, Park H, Pang S, Hwang YI, Lee WJ. 2005. Vitamin C downregulates interleukin-production by increasing reactive oxygen intermediate and mitogen-activated protein kinase signalling in B16F10 murine melanoma cells. Melanoma Res 13(6):549-554. (Pubitemid 38296890)
5. Coulter ID, Hardy ML, Morton SC, Hilton LG, Tu W, Valentine D, Shekelle PG. 2006. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen Intern Med 21(7):735-744. (Pubitemid 43973559)
6. Curry JM, Eubank TD, Roberts RD, Wang Y, Pore N, Maity A, Marsh CB. 2008. M-CSF signals through the MAPK ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo. PLoS ONE 3(10):e3405.
7. Ding YB, Shi RH, Tong JD, Li XY, Zhang GX, Xiao WM, Yang JG, Bao Y, Wu J, Yan ZG, Wang XH. 2005. PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system. Exp Oncol 27(2):108-113. (Pubitemid 41025731)
8. Epstein A, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54. (Pubitemid 32972036)
9. Faria DT, Nickoloff BJ, Poverini PJ, Kunkel S, Burdick M, Strieter RM. 1997. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen 5(4):310-322. (Pubitemid 127689592)
10. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. 2002. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277(41):38205-38211. (Pubitemid 35154674)
11. Gross RL. 2000. The effect of ascorbate on wound healing. Int Ophthalmol Clin 40(4):51-57.
12. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ. 2002. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 277(29):26351-26355. (Pubitemid 34967127)
13. Jiang BH, Agani F, Passaniti A, Semenza GL. 1997. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression. Cancer Res 57(23):5328-5335. (Pubitemid 27516371)
14. Johnson LJ, Meacham SL, Kruskall LJ. 2003. The antioxidants-Vitamin C, vitamin E, selenium, and carotenoids. J Agromedicine 9(1):65-82. (Pubitemid 37123718)
15. Kang JS, Cho D, Kim YI, Hahm E, Yang Y, Kim D, Hur D, Park H, Bang S, Hwang YI, Lee WJ. 2003. L-ascorbic acid (vitaminC) induces the apoptosis of B16 murine melanoma cells via a caspase-8-independent pathway. Cancer Immunol Immunother 52(11):693-698. (Pubitemid 37363640)
16. Kang JS, Cho D, Kim YI, Hahm E, Kim YS, Jin SN, Kim HN, Kim D, Hur D, Park H, Hwang YI, Lee WJ. 2005. Sodium ascorbate (vitaminC) induces apoptosis in melanoma cells via the down-regulation of transferrin receptor dependent iron uptake. J Cell Physiol 204(1):192-197. (Pubitemid 40776822)
17. Kang JS, Kim HN, Jung da J, Kim JE, Mun GH, Kim YS, Cho D, Shin DH, Hwang YI, Lee WJ. 2007. Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J Invest Dermatol 127(3):698-706.
18. Knowles HJ, Raval RR, Harris AL, Ratcliffe PJ. 2003. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63(8):1764-1768. (Pubitemid 36460834)
19. Koch S, Yao Ch, Grieb G, Prevel P, Noah EM, Steffens GC. 2006. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med 17(8):35-41.
20. Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M. 2005. Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology 68(2-3):138-145. (Pubitemid 41158969)
21. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. 2002. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16(12):1466-1471. (Pubitemid 34686328)
22. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21(12):3995-4004.
23. Lee WJ. 2009. The prospects of vitamin C in cancer therapy. Immune Netw 9(5):147-152.
24. Lee SK, Kang JS, Jung da J, Hur DY, Kim JE, Hahm E, Bae S, Kim HW, Kim D, Cho BJ, Cho D, Shin DH, Hwang YI, Lee WJ. 2008. Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production. J Cell Physiol 216(1):180-188. (Pubitemid 351813109)
25. Linster CL, Van Schaftingen E. 2007. Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274(1):1-22.
26. Mandl J, Szarka A, Bánhegyi G. 2009. Vitamin C: Update on physiology and pharmacology. Br J Pharmacol 157(7):1097-1110.
27. Martin BD, Schoenhard JA, Hwang JM, Sugden KD. 2006. Ascorbate is a prooxidant in chromium-treated human lung cells. Mutat Res 610(1-2):74-84. (Pubitemid 44508851)
28. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ. 1997. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90(9):3322-3331. (Pubitemid 27473400)
29. Meadows GG, Pierson HF, Abdallah RM. 1991. Ascorbate in the treatment of experimental transplanted melanoma. Am J Clin Nutr 54(6 Suppl):1284S-1291S.
30. Milkiewicz M, Mohammadzadeh F, Ispanovic E, Gee E, Haas TL. 2007. Static strain stimulates expression of matrix metalloproteinase-2 and VEGF in microvascular endothelium via JNK- and ERK-dependent pathways. J Cell Biochem 100(3):750-761. (Pubitemid 46180536)
31. Miura S, Tatsuguchi A, Wada K, Takeyama H, Shinji Y, Hiratsuka T, Futagami S, Miyake K, Gudis K, Mizokami Y, Matsuoka T, Sakamoto C. 2004. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am J Physiol Gastrointest Liver Physiol 287(2):G444-G451. (Pubitemid 38955265)
32. Munday K, Fulford A, Bates CJ. 2005. Vitamin C status and collagen crosslink ratios in Gambian children. Br J Nutr 93(4):501-507.
33. Muthuvel R, Venkataraman P, Krishnamoorthy G, Gunadharini DN, Kanagaraj P, Jone Stanley A, Srinivasan N, Balasubramanian K, Aruldhas MM, Arunakaran J. 2006. Antioxidant effect of ascorbic acid on PCB (Aroclor 1254) induced oxidative stress in hypothalamus of albino rats. J Clin Chim Acta 365(1-2):297-303. (Pubitemid 43196451)
34. Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N. 2003. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 48(6):1521-1529. (Pubitemid 36682359)
35. Norrby K. 2006. In vivo models of angiogenesis. J Cell Mol Med 10(3):588-612.
36. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. 2004. Vitamin C Pharmacokinetics: Implications for oral and intravenous use. Ann Intern Med 140(7):533-537.
37. Pai R, Szabo IL, Soreghan BA, Atay S, Kawanaka H, Tarnawski AS. 2001. PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem Biophys Res Commun 286(5):923-928. (Pubitemid 32924860)
38. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A. 2000. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14(1):34-44. (Pubitemid 30051577)
39. Riordan NH, Riordan HD, Meng X, Li Y, Jackson JA. 1995. Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypothesis 44(3):207-213.
40. Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A. 2004. Intravenous vitamin C as a chemotherapy agent: A report on clinical cases. P R Health Sci J 23(2):115-118.
41. Sato H, Takahashi M, Ise H, Yamada A, Hirose S, Tagawa Y, Morimoto H, Izawa A, Ikeda U. 2006. Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem Biophys Res Commun 342(1):107-112. (Pubitemid 43247366)
42. Siegel BV, Morton JI. 1984. Vitamin C and immunity: Influence of ascorbate on prostaglandin E2 synthesis and implications for natural killer cell activity. Int J Vitam Nutr Res 54(4):339-342. (Pubitemid 15158846)
43. Srivastava RK, Unterman TG, Shankar S. 2009. FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem 337(1-2):201-212.
44. Wintergerst ES, Maggini S, Hornig DH. 2006. Immune-enhancing role of vitamin C and zinc and effect on clinical conditions. Ann Nutr Metab 50(2):85-94. (Pubitemid 43328672)
45. Zetter BR. 1990. Cell motility in angiogenesis and tumor metastasis. Cancer Invest 8(6):669-671.
46. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL. 2000. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 60(6):1541-1545. (Pubitemid 30183422)
47. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D, Giaccia AJ. 2000. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14(4):391-396. (Pubitemid 30131884)